Industry Educational Session - The quadruplet era: Real-world experience of optimising care across diverse patient profiles in Multiple Myeloma- Sponsored by Sanofi
Tracks
-
| Sunday, April 19, 2026 |
| 1:20 PM - 2:05 PM |
| Room 4, Upper Level |
Details
This Sanofi-sponsored promotional symposium will focus on the real-world role of quadruplet treatment strategies in eligible patients with multiple myeloma. For UK healthcare professionals only.
Expert faculty will review the evolving quadruplet treatment landscape and, through case-based discussion, share insights from their early clinical experience of using quadruplet therapies across a diverse range of eligible patient profiles. They will also outline practical considerations for implementation and optimisation of patient outcomes in routine care.
The session will be chaired by Dr Jaimal Kothari and will draw on real-world experience from UK centres, with contributions from Dr Rachel Hall and Dr Jennifer Travers.
Sanofi products will be discussed. Prescribing information and adverse event reporting information will be available at the meeting.
MAT-XU-2600512 (v1.0) | Date of prep: March 2026
Speaker
Dr. Jaimal Kothari
Consultant Haematologist
Oxford University
Speaker One
Dr Jaimal Kothari is a Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust and Myeloma Lead for Oxford and the Thames Valley Cancer Alliance. He co-chairs the regional myeloma multidisciplinary team and plays a central role in protocol development, complex case management, and clinical trial delivery. As a Principal Investigator on multiple myeloma trials, he is closely involved in bringing novel therapies into clinical practice. He has published extensively and is a frequent speaker at regional and national meetings.
He is also co-host of The Myeloma Minutes, a widely recognised podcast supporting all those affected by myeloma.
Dr. Rachel Hall
Consultant Haematologist
University Hospitals Dorset
Speaker Two
Dr Rachel Hall is a Consultant Haematologist at the University Hospitals Dorset. Dr Hall qualified at University College London in 1993. She has worked in hospitals around the Wessex region training in Haematology and also worked for 2 years in Perth, Western Australia. She has been a Consultant Haematologist at The Royal Bournemouth Hospital since 2003 and has an interest in Myeloma, Lymphoma and Stem Cell Transplantation. She has set up specialist, multidisciplinary Myeloma clinics at Bournemouth and has a large clinical trial portfolio for Myeloma. She is also involved with Myeloma UK and runs regular patient information days and is on the clinical trials network steering board. She is currently the Chair of the UK Myeloma Society.
Dr Jennifer Travers
Doctor
NHS Greater Glasgow and Clyde
Speaker Three
Dr Jennifer Travers is a consultant haematologist at the Beatson, West of Scotland Cancer Centre specialising in plasma cell dyscrasias. Dr Travers graduated from the University of Glasgow School of Medicine, completing her junior doctor training in Glasgow, followed by completion of higher specialist training on the West of Scotland haematology Programme.
In her current role she works within the myeloma team at the Beatson and is involved in clinical myeloma service development, increasing multidisciplinary team working and expanding the myeloma clinical trial portfolio. Her main areas of interest include multiple myeloma and AL amyloidosis , being the Principal Investigator for a number of clinical trials, including NCRI Myeloma trials and has recently joined the UK Myeloma Research Alliance. Her general haematology commitment includes haematology consultation for the Golden Jubilee National Hospital where she is the Laboratory Director.
